Physiology of Menopause

On this page

Definition & Ovarian Aging - Ovary's Swan Song

  • Menopause: Permanent cessation of menses (≥12 months amenorrhea), no pathological cause.
  • Perimenopause: Transition before menopause; irregular cycles, hormonal fluctuations (↑FSH, variable ↓Estrogen).
  • Postmenopause: Period after Final Menstrual Period (FMP).
  • Ovarian Aging:
    • Key: Progressive ovarian follicular (oocyte) depletion via atresia.
    • Results in:
      • ↓ Inhibin B → ↑FSH (early, key marker).
      • ↓ Estrogen (later).
      • ↑LH.
    • ↓ Anti-Müllerian Hormone (AMH): Early indicator of declining ovarian reserve.

⭐ Average age of natural menopause in Indian women is around 46-47 years, slightly earlier than Western counterparts (global average ~51 years).

Hormonal Changes - Endocrine Shuffle

  • Primary Event: Ovarian follicular depletion (oocyte & granulosa cell loss).
  • Key Hormonal Shifts:
    • ↓ Estrogen (E2): Leads to menopausal symptoms. Initially fluctuates, then sustained low.
    • ↓ Progesterone: Due to anovulation.
    • ↓ Inhibin B: Early marker; its fall causes ↑FSH.
    • ↓ Anti-Müllerian Hormone (AMH): Reflects ovarian reserve; declines early.
    • ↑ FSH: Most sensitive marker; rises due to ↓estrogen & ↓inhibin feedback. Levels >30-40 mIU/mL are indicative.
    • ↑ LH: Rises, but less than FSH.
  • 📌 Mnemonic: FSH/LH High, Estrogen/Progesterone/Inhibin/AMH Low (FLH H EPLIA L).

Loading diagram…

⭐ A serum FSH level consistently >30-40 mIU/mL (with some labs using >25 mIU/mL) in conjunction with 12 months of amenorrhea is a key biochemical indicator of menopause.

Systemic Consequences - Estrogen's Echo

Estrogen withdrawal impacts multiple organ systems due to loss of its protective effects.

Organ SystemKey Changes & Pathophysiology (Estrogen ↓ leads to...)
VasomotorHot flushes, night sweats. Hypothalamic thermoregulatory instability (neurotransmitter imbalance: ↑Norepinephrine, ↓Serotonin).
UrogenitalGenitourinary Syndrome of Menopause (GSM): vaginal atrophy (dryness, dyspareunia), recurrent UTIs. ↓Collagen, ↓vascularity, ↑vaginal pH.
SkeletalOsteoporosis, ↑fracture risk. ↑RANKL/OPG ratio → ↑osteoclast activity, ↑bone resorption, ↓Bone Mineral Density (BMD).
Cardiovascular↑Coronary Artery Disease risk. Adverse lipids (↓HDL, ↑LDL, ↑Triglycerides), endothelial dysfunction, ↑inflammation.
CNSMood swings, sleep disturbances, "brain fog". Altered serotonin, norepinephrine levels, direct neuronal impact.
Skin & HairSkin thinning, ↓elasticity, hair loss. ↓Collagen synthesis, altered dermal matrix.

High‑Yield Points - ⚡ Biggest Takeaways

  • Depletion of ovarian follicles is the primary event leading to menopause.
  • ↓ Estrogen and ↓ Inhibin B cause a significant ↑ FSH and ↑ LH.
  • Elevated FSH (>30-40 mIU/mL) is the most reliable endocrine marker.
  • Estrone (E1) becomes the predominant estrogen, synthesized from androstenedione in peripheral adipose tissue.
  • Ovaries continue to produce androgens (e.g., androstenedione, testosterone) post-menopause.
  • Key symptoms include vasomotor instability (hot flashes) and urogenital atrophy due to estrogen deficiency_._

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS

Practice Questions: Physiology of Menopause

  1. 1. A postmenopausal woman with estrogen-dependent breast carcinoma has troublesome hot flushes. Which listed drug can provide nonhormonal symptom relief?

    • A. Yohimbine hydrochloride
    • B. Conjugated estrogen
    • C. Clonidine hydrochloride
    • D. Tamoxifen citrate
    Show answer

    Answer: C. Clonidine hydrochloride

    Clonidine hydrochloride - Clonidine hydrochloride is a centrally acting alpha-2 adrenergic agonist that reduces sympathetic outflow and helps stabilize the hypothalamic thermoregulatory center. - By reducing noradrenergic activity, clonidine hydrochloride decreases the frequency and severity of hot flashes when estrogen cannot be used. Yohimbine hydrochloride - Yohimbine hydrochloride is an alpha-2 adrenergic antagonist, unlike clonidine hydrochloride, and therefore increases sympathetic activity rather than suppressing it. - Increased sympathetic outflow may worsen thermoregulatory instability and vasomotor symptoms instead of reducing hot flashes. Conjugated estrogen - Conjugated estrogen effectively treats menopausal vasomotor symptoms by replacing deficient estrogen and stabilizing thermoregulation. - It is contraindicated in estrogen-dependent carcinoma, so a non-hormonal treatment is required in this patient. Tamoxifen citrate - Tamoxifen citrate is a selective estrogen receptor modulator used in breast cancer treatment, not a standard treatment for menopausal vasomotor symptoms. - Tamoxifen citrate commonly exacerbates hot flashes, making it unsuitable for preventing vasomotor symptoms.

  2. 2. A 35-year-old woman presents with 4 months of amenorrhea, increased FSH, LH, and decreased estrogen. What is the most likely diagnosis?

    • A. Functional hypothalamic amenorrhea
    • B. Intrauterine adhesions
    • C. Primary ovarian insufficiency
    • D. Polycystic ovary syndrome
    Show answer

    Answer: C. Primary ovarian insufficiency

    Primary ovarian insufficiency - Primary ovarian insufficiency fits amenorrhea before 40 years with high FSH and low estrogen, as seen in this 35-year-old woman. Functional hypothalamic amenorrhea - Functional hypothalamic amenorrhea produces low or inappropriately normal gonadotropins, unlike the elevated FSH and LH in this patient. Intrauterine adhesions - Intrauterine adhesions generally preserve ovarian hormone production and do not explain this patient's high FSH and low estrogen. Polycystic ovary syndrome - Polycystic ovary syndrome does not produce the high-FSH, low-estrogen pattern seen in this patient.

  3. 3. Levels of which of the following hormones are increased in postmenopausal women:

    • A. Estrogen
    • B. Progesterone
    • C. Cortisol
    • D. Follitropin
    Show answer

    Answer: D. Follitropin

    Follitropin - After menopause, ovarian estradiol, progesterone, and inhibin production fall markedly, reducing negative feedback on pituitary gonadotropin secretion - This results in a significant increase in the secretion of Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) from the anterior pituitary as the body attempts to stimulate ovarian function. Estrogen - Estrogen levels decrease significantly after menopause because depletion of the ovarian follicular reserve markedly reduces ovarian estradiol secretion. - The drop in estrogen is responsible for many menopausal symptoms, such as hot flashes and vaginal dryness. Progesterone - Progesterone levels also decrease substantially after menopause, as its primary source is the corpus luteum formed after ovulation, which no longer occurs. - Anovulatory cycles during the menopausal transition reduce progesterone exposure and can produce irregular bleeding before the final menstrual period; established menopause is characterized by amenorrhea. Cortisol - Cortisol levels are not directly affected by menopause in the same dramatic way as sex hormones. - Cortisol is a stress hormone produced by the adrenal glands, and its levels are primarily regulated by the hypothalamic-pituitary-adrenal (HPA) axis, which is distinct from the reproductive axis.

  4. 4. Which hormone does NOT primarily act through the cAMP second-messenger pathway?

    • A. Glucagon
    • B. Estrogen
    • C. Follitropin
    • D. Lutropin
    Show answer

    Answer: B. Estrogen

    Estrogen - Estrogen is a lipophilic steroid hormone that crosses the cell membrane and binds intracellular receptors. - The estrogen–receptor complex directly regulates gene transcription, so its primary mechanism does not depend on cAMP as a second messenger. Glucagon - Glucagon binds a Gs-coupled GPCR, activating adenylyl cyclase and increasing intracellular cAMP. - The resulting cAMP–protein kinase A pathway mediates glucagon’s effects, especially those regulating hepatic glucose metabolism. Lutropin - Lutropin binds a cell-surface Gs-coupled GPCR, which stimulates adenylyl cyclase and raises intracellular cAMP. - The cAMP pathway contributes to LH-mediated steroidogenesis and ovulation, so LH does not fit the exception. Follitropin - Follitropin binds a cell-surface Gs-coupled GPCR, activating adenylyl cyclase and increasing intracellular cAMP. - This cAMP signaling is important for FSH effects on gamete development, so FSH does not fit the exception.

  5. 5. A 35-year-old woman presents with amenorrhea for 4 months. Investigations show increased FSH and decreased estrogen levels. What is the most likely diagnosis?

    • A. Hypothalamic dysfunction
    • B. Premature ovarian failure
    • C. Pituitary dysfunction
    • D. Polycystic Ovary Syndrome
    Show answer

    Answer: B. Premature ovarian failure

    Premature ovarian failure - The combination of amenorrhea, increased FSH, and decreased estrogen at age 35 indicates ovarian failure with inadequate ovarian response to FSH stimulation. - Premature ovarian failure refers to cessation or significant loss of ovarian function before age 40, causing estrogen deficiency, amenorrhea, and potential infertility. Polycystic Ovary Syndrome - Polycystic Ovary Syndrome commonly causes anovulation with amenorrhea or oligomenorrhea, but ovarian estrogen production is generally maintained and androgen excess is typical. - PCOS usually has normal or low FSH rather than markedly increased FSH with decreased estrogen; this hormonal pattern indicates reduced ovarian reserve instead. Hypothalamic dysfunction - Hypothalamic dysfunction reduces GnRH pulsatility, producing low or inappropriately normal FSH and LH with reduced ovarian stimulation. - Functional hypothalamic amenorrhea is associated with stress, excessive exercise, or low body weight, and does not explain the elevated FSH described here. Pituitary dysfunction - Pituitary dysfunction causes insufficient gonadotropin secretion, so FSH is typically low or inappropriately normal rather than increased. - Although hyperprolactinemia from a pituitary adenoma can cause amenorrhea, it would not produce the elevated FSH and low-estrogen pattern given here.

  6. 6. All of the following are characteristic of the postmenopausal state EXCEPT:

    • A. High circulating FSH levels
    • B. Low circulating estrogen levels
    • C. Low circulating LH levels
    • D. Relative androgen predominance
    Show answer

    Answer: C. Low circulating LH levels

    Low circulating LH levels is the exception because LH rises after menopause as ovarian negative feedback declines. High circulating FSH levels occur because ovarian inhibin and estrogen production decline. Low circulating estrogen levels result from depletion of functional ovarian follicles. Relative androgen predominance reflects a greater decline in estrogen than in androgens, not an absolute androgen increase.

  7. 7. A 58-year-old postmenopausal woman has vulvar dryness and itching for 3 months. Examination shows diffuse vulvovaginal epithelial thinning without white plaques or scarring. Which treatment corrects the underlying atrophy?

    • A. Tamoxifen tablets
    • B. Estrogen ointment
    • C. Antihistamines
    • D. Clobetasol ointment
    Show answer

    Answer: B. Estrogen ointment

    Estrogen ointment treats the hypoestrogenic epithelial thinning responsible for this woman's vulvovaginal dryness and itching. Antihistamines may reduce itching but do not reverse estrogen-deficiency atrophy. Tamoxifen tablets are not a treatment for menopausal vulvovaginal atrophy and may contribute to vaginal dryness. Clobetasol ointment is first-line therapy for vulvar lichen sclerosus, which is not supported by the diffuse thinning without white plaques or scarring described here.

  8. 8. At puberty, a girl has approximately 300,000–400,000 primary oocytes across both ovaries. Approximately how many oocytes will she ovulate during her reproductive life?

    • A. 480 oocytes
    • B. 35,000 oocytes
    • C. 40,000 oocytes
    • D. 48 oocytes
    Show answer

    Answer: A. 480 oocytes

    480 oocytes - A reproductive lifespan of approximately 40 years with about 12 cycles annually gives 40 × 12 = 480 menstrual cycles. - Usually, one dominant follicle ovulates one oocyte per cycle; therefore, approximately 480 oocytes are ovulated, while most others undergo atresia. 35,000 oocytes - 35,000 greatly exceeds the roughly 400–500 lifetime ovulations because most follicles undergo atresia. 40,000 oocytes - 40,000 also greatly exceeds lifetime ovulations; ovarian reserve must not be equated with the number of oocytes released. 48 oocytes - 48 ovulations would correspond to only approximately four years at one ovulation per month, far shorter than the usual reproductive lifespan. - From menarche to menopause, roughly 40 years provide about 480 monthly cycles, making 48 substantially too low.

  9. 9. Gonadotrophins remain elevated after menopause for :

    • A. Rest of life
    • B. 5 years
    • C. 10 years
    • D. 2 years
    Show answer

    Answer: A. Rest of life

    Rest of life - After menopause, reduced ovarian estrogen production removes hypothalamic-pituitary negative feedback, maintaining elevated FSH and LH. - Persistent ovarian failure causes gonadotropins to remain elevated for the rest of life rather than only during a temporary transition. 10 years - Gonadotropin elevation persists because ovarian estrogen and progesterone production remains substantially reduced after menopause. - The hormonal change is permanent, so levels do not normalize or significantly decrease after 10 years. 2 years - Although FSH and LH are markedly elevated during the early postmenopausal period, this elevation does not resolve after two years. - Loss of ovarian negative feedback continues throughout life, making a two-year duration insufficient. 5 years - The absence of significant estrogen and progesterone production persists beyond the first five postmenopausal years. - Because ovarian failure is irreversible, gonadotropin levels remain elevated rather than returning to premenopausal values.

  10. 10. Menopause is associated with the following except:

    • A. Delusion
    • B. Loss of libido
    • C. Ischemic heart disease
    • D. Osteoporosis
    Show answer

    Answer: A. Delusion

    Delusion - Menopause may affect mood and cognition, but it does not typically produce delusions or other psychotic symptoms. - Delusion is primarily associated with psychotic disorders, so it is not a usual physiological consequence of menopause. Ischemic heart disease - Declining estrogen after menopause removes its cardioprotective effects and promotes adverse lipid and endothelial changes. - These changes increase the risk of ischemic heart disease, making it associated with menopause rather than the exception. Loss of libido - Reduced estrogen can cause vaginal dryness and dyspareunia, which may diminish sexual desire. - Hormonal changes affecting sexual function make loss of libido a recognized menopausal association. Osteoporosis - Estrogen helps maintain bone density, and its decline during menopause accelerates bone resorption and bone loss. - Progressive loss of bone mass increases the risk of osteoporosis and fractures in postmenopausal women.

Flashcards: Physiology of Menopause

  1. 1. Increased risk for breast carcinoma is associated with _____ menarche and _____ menopause

    Show answer

    early · late

  2. 2. In a post-menopausal woman with hyperplasia with atypia, management is done using

    Show answer

    hysterectomy

  3. 3. According to RCOG guidelines, in a patient with suspected post-menopausal ovarian cyst size >1cm on USG, the next step would be to perform

    Show answer

    CA-125 level measurements

  4. 4. In a post-menopausal woman with complex hyperplasia without atypia, management is done using

    Show answer

    progesterone rx

  5. 5. Leiomyomas (fibroids) increase with _____ (increased estrogen) and decrease with _____ (decreased estrogen)

    Show answer

    pregnancy · menopause

  6. 6. Premature menopause is menopause occurring before years.

    Show answer

    40

  7. 7. Postmenopausal status is a(n) contraindication to uterine artery embolisation

    Show answer

    relative

  8. 8. According to RCOG guidelines, in a patient with suspected post-menopausal ovarian cyst, the first step would be to perform a

    Show answer

    USG

Everything you need for Indian Medical PG prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE
75% OFFLimited time offer
GET 75% OFF